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OBJECTIVES This study evaluated the role of various clinical and echocardiographic parameters, including
the left atrial appendage (LAA) anterograde flow velocity, for prediction of the long-term
preservation of sinus rhythm (SR) in patients with successful cardioversion (CV) of
nonvalvular atrial fibrillation (AF).
BACKGROUND Echocardiographic parameters for assessing long-term SR maintenance after successful CV of
nonvalvular AF are not accurately defined.
METHODS Clinical, transthoracic echocardiographic and transesophageal echocardiographic (TEE)
data—measured in AF lasting 48 h—of 186 consecutive patients (116 men, mean age:
65  9 years) with successful CV (electrical or pharmacologic) were analyzed for assessment
of one-year maintenance of SR.
RESULTS At one-year follow-up, 91 of 186 (49%) patients who underwent successful CV continued to
have SR. Mean LAA peak emptying flow velocity was higher in patients remaining in SR for
one year than in those with AF relapse (41.7  20.2 cm/s vs. 27.7  17.0 cm/s; p  0.001).
On multivariate logistic regression analysis, only the mean LAA peak emptying velocity
40 cm/s (p  0.0001; 2: 23.9, odds ratio [OR]  5.2, confidence interval [CI] 95%  2.7
to 10.1) and the use of preventive antiarrhythmic drug treatment (p  0.0398; 2: 4.2;
OR 2.0, CI 95% 1.0 to 3.8) predicted the continuous preservation of SR during one year,
outperforming other univariate predictors such as absence of left atrial spontaneous echocar-
diographic contrast during TEE, the left atrial parasternal diameter 44 mm, left ventricular
ejection fraction 46% and AF duration 1 week before CV. The negative and positive
predictive values of the mean LAA peak emptying velocity 40 cm/s for assessing
preservation of SR were 66% (CI 95%  56.9 to 74.2) and 73% (CI 95%  62.4 to 83.3),
respectively.
CONCLUSIONS In TEE-guided management of nonvalvular AF, high LAA flow velocity identifies patients
with greater likelihood to remain in SR for one year after successful CV. Low LAA velocity
is of limited value in identifying patients who will relapse into AF. (J Am Coll Cardiol
2002;39:1443–9) © 2002 by the American College of Cardiology Foundation
Atrial fibrillation (AF), one of the most common rhythm
abnormalities of the heart, is associated with substantial
morbidity. Potential benefits of restoring and maintaining
sinus rhythm (SR) include elimination of arrhythmic symp-
toms, improved rate control and hemodynamics and re-
duced susceptibility to thromboembolic complications.
There are several proposed clinical and echocardiographic
predictors of arrhythmia recurrence in patients with success-
ful cardioversion (CV) of AF. Long-term maintenance of
SR is more likely in patients with shorter AF duration, smaller
left atrial (LA) size, preserved left ventricular (LV) function
and absence of mitral valve disease (1,2). However, the pre-
dictive value of these parameters for assessment of long-term
preservation of SR is far from the optimal (3,4). It would be
important to stratify the patients to tailor their treatment (i.e.,
the CV and preventive antiarrhythmic drug treatment).
In recent years, transesophageal echocardiography (TEE)
has emerged as an accepted tool to guide management of
patients with AF by screening for left atrial appendage
(LAA) thrombi and allowing earlier CV (5,6). Furthermore,
the assessment of thrombembolic risk by measurement of
LAA velocities during TEE in AF has become widely
accepted (7–9). Recent studies have suggested that long-
term SR maintenance may be predicted by evaluating LAA
velocities before CV (10,11). However, this finding has
been challenged by other reports (4), and the conclusions are
weakened by the small sample size and heterogeneous
patient population of the available studies. To clarify the
long-term prognostic value of the LAA anterograde flow
velocities, we evaluated, in a prospective, four-center, inter-
national study design, 193 consecutive patients with non-
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valvular AF lasting 1 year in whom the SR was success-
fully restored by either electric or pharmacologic CV.
METHODS
Study group. We prospectively studied 193 patients with
successful CV (electrical [n  147] or pharmacologic [n 
46]) of nonvalvular AF lasting 48 h and  1 year. Studies
were done at the Albert Szent-Gyo¨rgyi Medical University,
Szeged, Hungary; the SS. Annunziata Hospital, Savigliano,
Italy; the Mauriziano Umberto I Hospital, Torino, Italy;
and the Institute of Clinical Physiology, Pisa, Italy, between
January 1998 and February 2000. Clinical data including the
duration of AF were read from the patient’s record and
obtained by an interview with the patient, their attending
physician and their home practitioner. Duration of AF was
determined by careful examination of the patient’s medical
record, by questioning the patient and by reviewing all
previous electrocardiograms (ECGs) available. Exclusion
criteria were: duration of AF of 1 year, unknown duration
of AF, presence of prosthetic valve, pericarditis, pericardial
effusion, acute myocarditis, acute myocardial infarction,
chronic obstructive lung disease, pulmonary embolism, con-
genital heart disease, recent heart surgery, latent or manifest
hyperthyroidism, permanent pacemaker treatment, sick si-
nus syndrome, presence of atrial thrombus found by TEE
and organic valvular heart disease (aortic stenosis and
regurgitation, mitral and tricuspidal stenosis, mitral valve
insufficiency of valvular origin). Mitral valve regurgitation
due to mitral annular dilation was not included in the
exclusion criteria. Of the 193 patients studied, 80 (41%) had
a history of a previous episode of AF. All the enrolled
patients underwent a one-year follow-up program for as-
sessment of SR maintenance.
Echocardiography. Transthoracic echocardiography
(TTE) and TEE were performed 24 h before the CV
attempt with commercially available ultrasonographic sys-
tems (Hewlett-Packard Sonos 2500 and 5500, Acuson
XP125 and Sequoia; ATL HDI 9, Andover, Massachu-
setts). The TEE was performed with bi- or multiplane
probes with a 5- or 7-MHz transducer. The following TTE
measurements were taken by parasternal long-axis view
from two-dimensional targeted M-mode tracings according
to the recommendations of the American Society of Echo-
cardiography (12): LA diameter, LV end-diastolic and
end-systolic diameter, LV septal and posterior end-diastolic
wall thickness, ejection fraction (according to the Quinones
formula). The two-dimensional biplane area-length method
was used for ejection fraction calculation in patients with
previous infarction. All TTE indices were measured off-
line, using the integrated software of the echocardiographic
equipment, and were calculated as the average of five
consecutive cardiac cycles.
Following the TTE and after a 6-h fasting period, all
patients underwent TEE examination. During the TEE,
images were analyzed on-line by an experienced observer for
the presence of intracardiac thrombus. To view the maximal
size and to obtain the highest resolution of the LAA, the
most appropriate section was always used for the analysis.
The gain was continuously adjusted to ensure the best
possible visualization and to avoid noise artifact. A throm-
bus was considered to be present when a well-
circumscribed, echodense intracavitary mass that was acous-
tically distinct from the underlying endocardium was
detected (13). Patients demonstrating intracardiac throm-
bus during TEE were excluded from the study.
Videotape and/or digitally stored images were subse-
quently analyzed off-line for the presence of LA spontane-
ous echocardiographic contrast and mitral valve regurgita-
tion grade; this was done by two independent observers who
were unaware of the patient’s history. Spontaneous echo-
cardiographic contrast was defined as an intracavitary swirl-
ing smokelike echo within the left atrium or LAA (14).
Mitral regurgitation was qualitatively graded by color flow
Doppler mapping as none, mild, moderate or severe on the
basis of regurgitant jet area and spatial distribution of the
regurgitant flow (15). Differences between observers were
resolved by consensus; if observers could not agree, a third
and more experienced observer reviewed the study and his
judgment was binding. The LAA velocity profiles were
obtained by pulsed-wave Doppler interrogation 1 cm within
the orifice of the LAA and analyzed off-line from videotape
or digitally stored images by a single observer (A. P.), who
was unaware of the patient’s history. The LAA peak
emptying velocities were averaged with each RR-interval
over a minimum of five consecutive cardiac cycles (16,17).
Follow-up. Patients were followed-up regularly every three
months up to one year. Serial ECGs were recorded at each
visit to document the maintenance of SR or recurrence of
AF. In addition, referring physicians and patients were told
to confirm suspected recurrences of AF by a 12-lead ECG.
Initiation of preventive antiarrhythmic drug treatment dur-
ing the follow-up was decided by the patient’s referring
physician on the basis of integrated clinical assessment,
which included access to echocardiographic data. According
Abbreviations and Acronyms
AF  atrial fibrillation
CI  confidence interval
CV  cardioversion
ECG  electrocardiogram
LA  left atrial
LAA  left atrial appendage
LV  left ventricular
OR  odds ratio
ROC  receiver-operating characteristic
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to this, 72 of the 193 (37%) successfully converted patients
were treated by preventive antiarrhythmic drugs during the
follow-up period. Drug therapy for arrhythmia prevention
was flecainide (n  9), amiodarone (n  19), sotalol (n 
2) and propafenone (n  42).
Statistical analysis. All data are expressed as means  SD.
In the intergroup comparison of clinical and echocardio-
graphic continuous variables between patients with SR
preservation compared to AF relapse, the statistical signif-
icance was assessed by the unpaired Student t test. Com-
parison of proportions was performed using chi-square analysis
or the Fisher exact test as appropriate. Receiver-operating
characteristic (ROC) analysis was used to determine optimal
cutoff values of continuous variables for prediction of one-year
SR preservation. The ROC curve represents the relationship
between sensitivity and specificity, by plotting true-positive
rate (sensitivity) against the false-positive rate (specificity), as
the cutoff level of the model varies. The best cutoff value was
defined as the point with the highest sum of sensitivity and
specificity. The area under the ROC curve was used to quantify
the ability of the mean LAA emptying velocity to predict the
one-year SR maintenance accurately. Univariate and multivar-
iate logistic regression models (toward forward stepwise pro-
cedure) were used to control for all possible confounding
factors and to assess interaction between variables for assess-
ment of one-year SR maintenance. The univariate and multi-
variate odds ratios (ORs) and their corresponding 95% confi-
dence intervals (CIs) are given. All tests were two-sided, and a
p value 0.05 was considered statistically significant. All
analyses were performed by an SPSS 9.0 software package
(SPSS Inc., Chicago, Illinois).
RESULTS
Follow-up. During the follow-up period, four patients
died (two from noncardiac and two from cardiac causes),
and three patients were lost for other reasons. The one-year
follow-up was finally completed in 186 patients (94%), with
successful CV of nonvalvular AF. At the end of the one-year
period, 91 (49%) patients remained in SR and AF recurred
in 95 (51%) patients. Patients’ demographic and clinical
characteristics are shown in Table 1.
Clinical parameters and maintenance of SR. There were
no differences in age, gender and underlying diseases be-
tween patients with and without SR maintenance (Table 1).
Patients who continued to have SR for one year had shorter
AF duration before CV compared to those with AF relapse.
On the basis of ROC analysis (Fig. 1), an AF duration of
one week (present in 71 patients, 38%) provided the best
separation between patients with and without SR mainte-
nance (shorter in patients with SR preservation). Antiar-
rhythmic drug use was more frequent in patients who
continued to have SR at one-year follow-up compared to
those with AF relapse (Table 1).
Echocardiographic parameters and maintenance of SR.
On the basis of TTE parameters, patients without AF
relapse had lower LA parasternal diameter. Left ventricular
ejection fraction tended to be higher in those patients who
continued to have SR for one year, whereas LV wall
thickness and end-diastolic diameter were not related to the
long-term maintenance of SR (Table 1). On the basis of the
ROC analysis (Fig. 1), cutoff values of an LA diameter
44 mm and an LV ejection fraction 46% provided the
Table 1. Clinical and Echocardiographic Variables in Patients With Successful Cardioversion of






(n  95) p Value
Clinical variables
Mean age (yrs) 65.1  9.9 64.6  10.7 65.4  9.1 NS
Male gender (%) 116 (62%) 60 (66%) 56 (59%) NS
Diabetes (%) 13 (7%) 5 (5%) 8 (8%) NS
Hypertension (%) 119 (64%) 57 (63%) 62 (65%) NS
Ischemic heart disease (%) 24 (13%) 11 (12%) 13 (14%) NS
Prior myocardial infarction (%) 14 (8%) 5 (6%) 9 (9%) NS
Atrial fibrillation duration (days) 36  62 33  39 39  56  0.01
Antiarrhythmic drug use during follow-up 66 (35%) 39 (43%) 27 (28%)  0.05
Transthoracic echocardiographic variables
LA diameter (mm) 44.2  6.2 43.0  5.9 45.4  6.3  0.01
LV ejection fraction (%) 54.6  11.9 55.7  10.9 53.5  12.7 NS
LV EDD (mm) 53.2  6.5 52.9  6.7 53.4  6.4 NS
LV mass (g) 222.4  59.3 216.9  57.6 227.5  60.8 NS
Transesophageal echocardiographic variables
Presence of left atrial SEC (%) 87 (47%) 34 (37%) 53 (56%)  0.05
Degree of mitral valve regurgitation (%)
Absent or mild 155 (83%) 81 (89%) 74 (78%) NS
Medium 23 (12%) 6 (7%) 17 (18%)
Severe 8 (4%) 4 (4%) 4 (4%)
Mean LAA peak anterograde flow (cm/s) 34.6  19.9 41.7  20.3 27.7  17.0  0.001
AF  atrial fibrillation; EDD  end-diastolic diameter; LA  left atrial; LAA  left atrial appendage; LV  left ventricular;
SEC  spontaneous echo cardiographic contrast; SR  sinus rhythm.
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best separation between patients with and without one-year
SR maintenance. According to these cutoff points, 85 (46%)
patients had an LA diameter of 44 mm and 142 (76%)
patients had an ejection fraction of 46%. Transesophageal
parameters could separate the two groups on the basis of the
mean LAA peak anterograde flow (higher in patients with
SR maintenance) and presence of LA spontaneous echocar-
diographic contrast (less frequent in patients with SR mainte-
nance) whereas no difference could be observed when the
degree of mitral valve regurgitation was considered (Table 1).
According to the ROC analysis of derived mean LAA antero-
grade flow velocity cutoff of 40 cm/s, 70 patients (38%) had a
mean LAA peak anterograde velocity higher than 40 cm/s.
Typical examples of high and low velocity profiles of the LAA
in AF, obtained by pulsed Doppler during TEE in patients
with and without one-year maintenance of SR, are shown in
Figures 2 and 3, respectively.
Prediction of long-term maintenance of SR by integrated
clinical and echocardiographic variables. Univariate lo-
gistic regression analysis revealed that mean LAA peak
anterograde flow velocity 40 cm/s was the strongest
predictor of one-year SR maintenance followed by AF
duration 1 week before CV, LA diameter 44 mm, LV
ejection fraction 46%, absence of LA spontaneous echo-
cardiographic contrast on TEE and use of preventive
antiarrhythmic drug during follow-up. Using multivariate
logistic regression analysis, only two parameters proved to
be independent predictors of one-year preservation of SR:
the mean LAA peak anterograde velocity 40 cm/s (OR 
5.2, CI 95% 2.7 to 10.1; 2 23.9, p 0.0001) and the use
of preventive antiarrhythmic drug during follow-up (OR 
2.0, CI 95%  1.0 to 3.8; 2 4.2, p  0.05) (Table 2). The
diagnostic values of the different clinical and echocardio-
graphic parameters are presented in Table 3.
Figure 1. Receiver-operating curves of left atrial appendage (LAA) flow, atrial fibrillation (AF) duration, left atrial (LA) diameter and left ventricular
ejection fraction (LVEF) for prediction of one-year maintenance of sinus rhythm. The area under the curve is given. CI  confidence interval.
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DISCUSSION
Measurement of the LAA emptying velocity profile by TEE
before CV in patients with nonvalvular AF provides impor-
tant information for prediction of long-term SR mainte-
nance.
Comparison with previous studies. Previous studies have
already demonstrated that the LAA velocity is related to the
LA size (18,19) and the duration of AF (8,16), all of which
are predictors of long-term SR maintenance. However,
conflicting and scarce data exist on the usefulness of LAA
flow to predict long-term preservation of SR (4,10,11). The
discrepancy of the data can be easily reconciled by taking
into account the limited sample size and variable inclusion
criteria of the previous reports. Our study has distinct
features: 1) the prospective, multicenter design, whereas all
previous studies came from single-center experience; 2) the
large number of patients enrolled (186 patients, whereas
previous studies enrolled 38 to 75 patients); and 3) the strict
Figure 2. Pulsed Doppler tracing of the left atrial appendage (LAA) obtained by transesophageal echocardiography in atrial fibrillation showing high peak
emptying flow velocity signals in a patient who preserved the sinus rhythm for one year. The mean LAA flow peak anterograde velocity was 52 cm/s.
Figure 3. Pulsed Doppler tracing of the left atrial appendage (LAA) obtained by transesophageal echocardiography in atrial fibrillation (AF) showing low
peak emptying flow velocity signals in a patient with AF relapse during the follow-up. The mean LAA peak anterograde velocity was 18 cm/s.
1447JACC Vol. 39, No. 9, 2002 Antonielli et al.
May 1, 2002:1443–9 LAA Flow Predicts Long-Term SR Maintenance in AF
selection criteria, which allowed us to exclude patients with
valvular heart disease. The relatively large sample size
enabled us to demonstrate that mean LAA peak emptying
velocity has independent and additive prognostic value over
other echocardiographic and clinical predictors, such as LA
diameter, LA spontaneous echocardiographic contrast, ejec-
tion fraction and duration of AF whose prognostic value is
totally eclipsed by LAA flow.
The possible link between LAA velocity and prediction
of SR maintenance. In chronic nonvalvular AF, a time-
related structural and histologic remodeling develops both
in the LAA and in the left atrium (chamber dilation, loss of
myofibrils, fragmentation of sarcoplasmatic reticulum and
marked collagen formation) (20–25). These unfavorable
degenerative changes may cause inhomogeneity of atrial
repolarization, nonuniform anisotropy or slowing of con-
duction, and they are important components in the patho-
genesis of AF (25,26). Loss of contractile elements of LAA
may result in its reduced mechanical function, which could
be expressed in low LAA flow velocities profile. However,
according to our knowledge, there is no published data in
the literature studying the direct link between LAA flow
and histopathologic changes in the appendage in patients
with nonvalvular AF.
Study limitations. The study population may appear het-
erogeneous with regard to the clinical parameters such as
duration of AF, mode of CV, type of preventive antiar-
rhythmic therapy, but it corresponds to the variable clinical
situations encountered in hospital practice. Therefore, the
conclusions of this study can be reasonably applied to the
general population of patients with nonvalvular AF of
1-year duration. It is important to note that the duration
of follow-up influences the rate of preserved SR to some
extent and may, therefore, affect the relationship between
clinical parameters and outcome. Consequently, our conclu-
sions are not necessarily valid for a longer follow-up period.
Selection of patients for antiarrhythmic drug treatment may
have introduced a potential bias that might have influenced the
results to some extent. Nonetheless, the postcardioversion
treatment was not randomized in our study the antiarrhythmic
drug use were equally distributed in patients with high and low
LAA flow.
Short, asymptomatic episodes of AF between the regular
follow-up visits may have been missed in some patients, and
this potential misclassification could have resulted in an
underestimation of some difference.
The LAA areas were not assessed in our study; however,
these measurements are inherently prone to substantial
interobserver variability during both data registration and
off-line analysis (8,27), possibly due to the complex three-
dimensional anatomy of the LAA. In contrast, assessment
of LAA function by Doppler echocardiography during TEE
could be easily performed and it was reproducible and
clinically highly relevant (7–9). The negative predictive
value of LAA emptying flow velocity 40 cm/s for predic-
tion of long-term SR preservation was relatively low, with a
value of 66%. Thus, we do not know accurately whether a
patient with low LAA flow velocity will relapse into AF
within one year.
Conclusions. Our study showed that high LAA flow
identifies those patients who will remain in SR for one year.
Conversely, low LAA velocity is of limited value in identi-
fying patients who will relapse into AF. In patients with
nonvalvular AF, the same TEE-derived parameter often
Table 2. Univariate and Multivariate Predictors of One-Year Maintenance of SR
p Value Chi-Square OR (95% CI)
Univariate predictors
Preventive antiarrhythmic drug use during follow-up 0.05 4.2 1.9 (1.0–3.5)
Absence of left atrial SEC during TEE 0.05 6.3 2.1 (1.2–3.8)
LV ejection fraction 46% 0.05 6.5 2.5 (1.2–5.2)
LA diameter 44 mm 0.01 9.3 2.5 (1.4–4.5)
AF duration 1 week 0.01 9.4 2.6 (1.4–4.8)
Mean peak anterograde LAA flow velocity 40 cm/s 0.0001 24 5.1 (2.7–9.8)
Multivariate predictors
Preventive antiarrhythmic drug use during follow-up 0.05 4.2 2.0 (1.0–3.8)
Mean peak anterograde LAA flow velocity 40 cm/s 0.0001 23.9 5.2 (2.7–10.1)
CI  confidence interval; OR  odds ratio; TEE  transesophageal echocardiography; other abbreviations as in Table 1.
Table 3. Diagnostic Value of Clinical and Echocardiographic Parameters for Assessment of











LAA peak emptying flow 40 cm/s 56 80 73 66 68
LA diameter 44 mm 57 65 61 61 61
AF duration 1 week 49 72 63 60 61
Absence of LA SEC during TEE 63 56 58 61 59
LVEF 46% 85 32 54 68 58
ACC  accuracy; LVEF  left ventricular ejection fraction; NPV  negative predictive value; PPV  positive predictive value;
SENS  sensitivity; SPEC  specificity; other abbreviations as in Table 2.
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used to assess the embolic risk and to predict the chances of
acute success of CV (28) (i.e., LAA flow) can be of use in
predicting one-year outcome of successful CV.
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